Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Agnosia 6 Pain 5 Breast Neoplasms 3 Pain, Postoperative 2 Cancer Pain 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Supratentorial Neoplasms 1 Postoperative Cognitive Complications 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Chronic Pain 1

Interventions

Carboplatin 340 Cisplatin 238 Paclitaxel 203 Radiotherapy 195 Pemetrexed 187 Docetaxel 169 Gemcitabine 157 pembrolizumab 141 Erlotinib Hydrochloride 107 Etoposide 99 Magnetic Resonance Spectroscopy 93 Bevacizumab 91 Specimen Handling 76 Nivolumab 73 Radiosurgery 72 durvalumab 69 Vinorelbine 54 osimertinib 53 Gefitinib 49 Drug Therapy 49 atezolizumab 42 Irinotecan 42 Radiation 40 Topotecan 39 Biopsy 39 Standard of Care 38 Cyclophosphamide 38 Cetuximab 35 Blood Specimen Collection 33 Taxes 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lung Neoplasms × Analgesics, Opioid × Clear all

NCT02359175 2023-06-27

SEAVATS

Odense University Hospital

Phase 4 Completed

Lung Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡